Your browser doesn't support javascript.
loading
Altered endosomal-lysosomal biogenesis in melanoma.
Lam, Giang T; Sorvina, Alexandra; Martini, Carmela; Prabhakaran, Sarita; Ung, Ben S-Y; Lazniewska, Joanna; Moore, Courtney R; Beck, Andrew R; Hopkins, Ashley M; Johnson, Ian R D; Caruso, Maria C; Hickey, Shane M; Brooks, Robert D; Jackett, Louise; Karageorgos, Litsa; Foster-Smith, Erwin J; Malone, Victoria; Klebe, Sonja; O'Leary, John J; Brooks, Douglas A; Logan, Jessica M.
Afiliação
  • Lam GT; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Sorvina A; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Martini C; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Prabhakaran S; Department of Anatomical Pathology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Ung BS; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Lazniewska J; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Moore CR; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Beck AR; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Hopkins AM; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Johnson IRD; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Caruso MC; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Hickey SM; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Brooks RD; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Jackett L; Anatomical Pathology Department, Austin Hospital, Melbourne, Vic, Australia.
  • Karageorgos L; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Foster-Smith EJ; Royal Adelaide Hospital, Adelaide, SA, Australia.
  • Malone V; Department of Histopathology, Trinity College Dublin, Ireland.
  • Klebe S; Department of Anatomical Pathology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia; Department of Surgical Pathology, SA Pathology at Flinders Medical Centre, Adelaide, SA, Australia.
  • O'Leary JJ; Department of Histopathology, Trinity College Dublin, Ireland.
  • Brooks DA; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia.
  • Logan JM; Clinical and Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, SA, Australia. Electronic address: Jessica.logan@unisa.edu.au.
Neoplasia ; 43: 100924, 2023 09.
Article em En | MEDLINE | ID: mdl-37562257
ABSTRACT
Cutaneous melanoma is the deadliest form of skin neoplasm and its high mortality rates could be averted by early accurate detection. While the detection of melanoma is currently reliant upon melanin visualisation, research into melanosome biogenesis, as a key driver of pathogenesis, has not yielded technology that can reliably distinguish between atypical benign, amelanotic and melanotic lesions. The endosomal-lysosomal system has important regulatory roles in cancer cell biology, including a specific functional role in melanosome biogenesis. Herein, the involvement of the endosomal-lysosomal system in melanoma was examined by pooled secondary analysis of existing gene expression datasets. A set of differentially expressed endosomal-lysosomal genes was identified in melanoma, which were interconnected by biological function. To illustrate the protein expression of the dysregulated genes, immunohistochemistry was performed on samples from patients with cutaneous melanoma to reveal candidate markers. This study demonstrated the dysregulation of Syntenin-1, Sortilin and Rab25 may provide a differentiating feature between cutaneous melanoma and squamous cell carcinoma, while IGF2R may indicate malignant propensity in these skin cancers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Melanoma Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Melanoma Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article